Price

rebased to 0%

AMGN, solidPALI, dashed

AMGNAmgen Inc

460.55+0.06%· post 460.42

Mkt cap$249.0BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

PALIPalisade Bio, Inc.

1.14−2.14%· post 1.14

ClosedNov 6 '26

Mkt cap$202.2MRevenue$500,000Q2 FY26Revenue—

vs

Compare

ClosedNov 6 '26

AMGNAmgen Inc

vs

PALIPalisade Bio, Inc.

460.55+0.06%post 460.42

Price

1.14−2.14%post 1.14

$249.0B

Mkt cap

$202.2M

Q3 FY26$10.4B

Revenue

$500,000Q2 FY26

FY25$36.8B

Revenue

—

AMGN compared with PALI: revenue, margins and what each company keeps, and the suppliers and customers both name